These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27477890)

  • 1. Hypophosphataemia and parenteral nutrition; biochemical monitoring, incidence and outcomes.
    Fung EC; Wickramasinghe SR; Panteli JV; Crook MA
    Br J Biomed Sci; 2017 Jan; 74(1):48-51. PubMed ID: 27477890
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors contributing to the development of hypophosphataemia when refeeding using parenteral nutrition.
    Marvin VA; Brown D; Portlock J; Livingstone C
    Pharm World Sci; 2008 Aug; 30(4):329-35. PubMed ID: 18373276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refeeding hypophosphataemia is more common in enteral than parenteral feeding in adult in patients.
    Zeki S; Culkin A; Gabe SM; Nightingale JM
    Clin Nutr; 2011 Jun; 30(3):365-8. PubMed ID: 21256638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refeeding hypophosphataemia in malnutrition patients: prevention and treatment.
    Gentile MG; Manna GM
    Clin Nutr; 2012 Jun; 31(3):429; author reply 430. PubMed ID: 22154934
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypophosphatemia, Hypomagnesemia, and Hypokalemia in Pediatric Patients Before and During Exclusive Individualized Parenteral Nutrition.
    Hortencio TD; Nogueira RJ; de Lima Marson FA; Ribeiro AF
    Nutr Clin Pract; 2016 Apr; 31(2):223-8. PubMed ID: 26869613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting refeeding hypophosphataemia: insulin growth factor 1 (IGF-1) as a diagnostic biochemical marker for clinical practice.
    Goyale A; Ashley SL; Taylor DR; Elnenaei MO; Alaghband-Zadeh J; Sherwood RA; le Roux CW; Vincent RP
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):82-7. PubMed ID: 24609720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophosphatemia in a Specialized Intestinal Failure Unit: An Observational Cohort Study.
    Eriksen MK; Baunwall SMD; Lal S; Dahlerup JF; Hvas CL
    JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1259-1267. PubMed ID: 32841404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypercalcaemia and hypophosphataemia with an optimised preterm parenteral nutrition formulation in two epochs of differing phosphate supplementation.
    Mulla S; Stirling S; Cowey S; Close R; Pullan S; Howe R; Radbone L; Clarke P
    Arch Dis Child Fetal Neonatal Ed; 2017 Sep; 102(5):F451-F455. PubMed ID: 28456753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refeeding Hypophosphatemia in Patients Receiving Parenteral Nutrition: Prevalence, Risk Factors, and Predicting Its Occurrence.
    Wong GJY; Pang JGT; Li YY; Lew CCH
    Nutr Clin Pract; 2021 Jun; 36(3):679-688. PubMed ID: 32692907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between hypophosphataemia and outcomes during low-intensity and high-intensity continuous renal replacement therapy.
    Bellomo R; Cass A; Cole L; Finfer S; Gallagher M; Kim I; Lee J; Lo S; McArthur C; McGuinness S; Norton R; Myburgh J; Scheinkestel C
    Crit Care Resusc; 2014 Mar; 16(1):34-41. PubMed ID: 24588434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral iron as a cause of hypophosphataemia.
    Fernández-Fernández FJ; Martín-Fernández A
    BMJ; 2014 Jul; 349():g4616. PubMed ID: 25027747
    [No Abstract]   [Full Text] [Related]  

  • 12. [Severe hypophosphataemia after starting parenteral nutrition in a patient with an intestinal fistula].
    Temprano JL; Bretón I; Zugasti A; Cuerda C; Camblor M; Pérez-Díaz MD; García P
    Nutr Hosp; 2004; 19(4):243-7. PubMed ID: 15315116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Institutional Change in Continuous Renal Replacement Therapy.
    Busch RA; Curtis CS; Kight CE; Leverson GE; Ma Y; Maursetter L; Kudsk KA
    Nutr Clin Pract; 2017 Apr; 32(2):245-251. PubMed ID: 27589256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypophosphatemia in parenteral nutrition: prevention and associated risks factors].
    Llop Talaverón JM; Comas Sugrañes D; Badía Tahull MB; Sáez Fernández A; Jódar Masanés R; Gómez Sáez JM
    Nutr Hosp; 2004; 19(6):362-6. PubMed ID: 15672652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early hypophosphatemia in very low birth weight preterm infants.
    Pająk A; Królak-Olejnik B; Szafrańska A
    Adv Clin Exp Med; 2018 Jun; 27(6):841-847. PubMed ID: 29790700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatemia occurs with insulin administration during refeeding by total parenteral nutrition in rats.
    Kawamura H; Tanaka S; Uenami Y; Tani M; Ishitani M; Morii S; Sakaue M; Ito M
    J Med Invest; 2018; 65(1.2):50-55. PubMed ID: 29593193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early hypophosphataemia in at risk newborns. Frequency and magnitude].
    Bustos Lozano G; Hidalgo Romero Á; Melgar Bonis A; Ureta Velasco N; Orbea Gallardo C; Pallás Alonso C
    An Pediatr (Engl Ed); 2018 Apr; 88(4):216-222. PubMed ID: 28587906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of hypophosphatemia in not critically ill patients with enteral feeding].
    Fernández López MT; Gómez Márquez ÁM; Casado Vázquez L; Alonso Urrutia S; Bardasco Alonso ML; Rivero Luis MT; Fernández Pérez E; Barreiros Blanco S; Alves Pérez MT; Mato Mato JA
    Nutr Hosp; 2017 Jul; 34(4):761-766. PubMed ID: 29094996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypophosphataemia due to intraperitoneal nutrition in a CAPD patient.
    Ghattaora R; Doyle S; Farrington K
    Nephrol Dial Transplant; 1996 Jul; 11(7):1365-6. PubMed ID: 8672043
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphate supplementation for hypophosphataemia and parenteral nutrition.
    Hicks W; Hardy G
    Curr Opin Clin Nutr Metab Care; 2001 May; 4(3):227-33. PubMed ID: 11517357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.